Merrimack Pharmaceuticals are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Merrimack is advancing a robust pipeline of clinical and early-stage biologics that represent the next generation of patient-directed, targeted therapies.
Antibody targeted nanocarrier
Merrimack Pharmaceuticals Inc.
1 Kendall Square Cambridge, MA 02139 USA